Shortcomings in the current treatment of epilepsy

References

• Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 346(8968), 140–144 (1995).
   PubMed Web of Science ®Google Scholar
• Sander JW. The epidemiology of epilepsy revisited. Curr. Opin. Neurol. 16(2), 165–170 (2003).
   PubMed Web of Science ®Google Scholar
• Sander JW. Some aspects of prognosis in the epilepsies: a review. Epilepsia 34(6), 1007–1016 (1993).
   PubMed Web of Science ®Google Scholar
• Banerjee PN, Hauser WA. Incidence and prevalence. In: Epilepsy: A Comprehensive Textbook (Second edition). Engel JJ, Pedley TA (Eds). Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA, USA 45–56 (2008).
   Google Scholar
• Beghi E, Sander JW. The natural history and prognosis of epilepsy. In: Epilepsy: A Comprehensive Textbook (Second edition). Engel JJ, Pedley TA (Eds). Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA, USA, 65–70 (2008).
   Google Scholar
• Delasiauve LJF. Traite de l’épilepsie. Masson, Paris, France (1854).
   Google Scholar
• Reynolds JR. The Diagnosis of Diseases of the Brain, Spinal Cord, Nerves and Their Appendages. J Churchill, London, UK (1855).
   Google Scholar
• Gowers WR. Epilepsy And Other Chronic Convulsive Disorders (First edition). J & A Churchill, London, UK (1881).
   Google Scholar
• Herpin T. Des Accès Incomplets d’Épilepsie. Balliere, Paris, France (1867).
   Google Scholar
• Taylor JE. Selected Writings of John Hughlings Jackson. Staples Press, London, UK (1958).
   Google Scholar
• Berg AT. Epilepsies. In: Atlas of the Epilepsies. Paniatopoulos CP (Ed.). Springer, Heidelberg, Germany, 6–10 (2010).
   Google Scholar
• Gudmundsson G. Epilepsy in Iceland. Acta Neurol. Scandinav. 43(Suppl. 25), 4–124 (1966).
   Google Scholar
• Hart YM, Sander JW, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet 336(8726), 1271–1274 (1990).
   PubMed Web of Science ®Google Scholar
• Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 41(7), 965–972 (1991).
   PubMed Web of Science ®Google Scholar
• Beghi E, Ciccone A. Recurrence after a first unprovoked seizure. Is it still a controversial issue? First Seizure Trial Group (first). Seizure 2(1), 5–10 (1993).
   PubMedGoogle Scholar
• First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 43, 478–483 (1993).
   PubMed Web of Science ®Google Scholar
• Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 49(4), 991–998 (1997).
   PubMed Web of Science ®Google Scholar
• MacDonald B. The prognosis of epilepsy. Seizure 10(5), 347–358 (2001).
   PubMed Web of Science ®Google Scholar
• Locock C. Discussion following Dr Sieveking ‘Analysis of fifty-two cases of epilepsy observed by the author’. Med. Times Gaz. i, 524–526 (1857).
   Google Scholar
• Locock C. Discussion of paper by E.H.Sieveking. Analysis of fifty-two cases of epilepsy observed by the author. Lancet 59, 527 (1857).
   Google Scholar
• Wilks S. Bromide and iodide of potassium in epilepsy. Med. Times Gaz. ii, 635–636 (1861).
   Google Scholar
• Shinnar S, Berg AT. Does antiepileptic drug therapy prevent the development of ‘chronic’ epilepsy? Epilepsia 37(8), 701–708 (1996).
   PubMed Web of Science ®Google Scholar
• Prenx PM, Duret-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol. 4, 21–31 (2005).
   PubMed Web of Science ®Google Scholar
• Hauser AW, Lee JW. Do seizures beget seizures? Prog. Brain Res. 135, 215–219 (2002).
   PubMed Web of Science ®Google Scholar
• Adie WJ. Pyknolepsy: a form of epilepsy occurring in children, with a good prognosis. Brain 47, 96–101 (1924).
   Google Scholar
• Loiseau P, Pestre M, Dartigues JF, Commenges D, Barberger-Gateau C, Cohada S. Long-term prognosis in two forms of childhood epilepsy: typical absences and epilepsy with Rolandic (centrotemporal) EEG foci. Ann. Neurol. 13, 642–648 (1993).
   Google Scholar
• Annegers JF, Hauser WA, Elveback LR, Kurland LT. The risk of epilepsy following febrile convulsions. Neurology 29(3), 297–303 (1979).
   PubMed Web of Science ®Google Scholar
• Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 73(13), 1041–1045 (2009).
   PubMed Web of Science ®Google Scholar
• Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52(4), 657–678 (2011).
   PubMed Web of Science ®Google Scholar
• Costa J, Fareleira F, Ascenção R, Borges M, Sampaio C, Vaz-Carneiro A. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia 52(7), 1280–1291 (2011).
   PubMed Web of Science ®Google Scholar
• Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 3(10), 618–621 (2004).
   PubMed Web of Science ®Google Scholar
• Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J; N166 Levetiracetam Study Group. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70(8), 607–616 (2008).
   PubMed Web of Science ®Google Scholar
• Fattore C, Boniver C, Capovilla G et al. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 52(4), 802–809 (2011).
   PubMed Web of Science ®Google Scholar
• Reynolds EH. Do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible. BMJ 310(6973), 176–177 (1995).
   PubMedGoogle Scholar
• MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann. Neurol. 48(6), 833–841 (2000).
   PubMed Web of Science ®Google Scholar
• Camfield C, Camfield P, Gordon K, Dooley J. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology 46(1), 41–44 (1996).
   PubMed Web of Science ®Google Scholar
• Brodie MJ. Diagnosing and predicting refractory epilepsy. Acta Neurol. Scand., Suppl.c 181, 36–39 (2005).
   PubMedGoogle Scholar
• Deckers CL, Genton P, Sills GJ, Schmidt D. Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res. 53(1–2), 1–17 (2003).
   PubMed Web of Science ®Google Scholar
• Sisodiya SM. Mechanisms of antiepileptic drug resistance. Curr. Opin. Neurol. 16(2), 197–201 (2003).
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Kerb R, Weale ME et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med. 348(15), 1442–1448 (2003).
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N. Engl. J. Med. 342(5), 314–319 (2000).
   PubMed Web of Science ®Google Scholar
• French JA. Refractory epilepsy: clinical overview. Epilepsia 48(Suppl. 1), 3–7 (2007).
   PubMed Web of Science ®Google Scholar
• Sillanpää M, Schmidt D. Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. Brain 135(Pt 7), 2256–2262 (2012).
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Cellular action of antiepileptic drugs. In: Antiepileptic Drugs. Pharmacology and Therapeutics. Eadie MJ, Vajda FJE (Eds). Springer, Berlin, Germany, 123–150 (1999).
   Google Scholar
• Brodie MJ, Sills GJ. Combining antiepileptic drugs – rational polytherapy? Seizure 20(5), 369–375 (2011).
   PubMed Web of Science ®Google Scholar
• Jackson JH. Remarks on the diagnosis and treatment of diseases of the brain. Br. Med. J. 2(1437), 59–63 (1888).
   PubMedGoogle Scholar
• Jackson JH. A study of convulsions. Transact. St Andrews Med. Graduates Assoc. 3, 162–204 (1870).
   Google Scholar
• Jackson JH. On the anatomical and physiological localisation of movements in the brain. Lancet 101, 232–235 (1873).
   Google Scholar
• Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis. Epilepsia 41(10), 1269–1275 (2000).
   PubMed Web of Science ®Google Scholar
• Eadie MJ. Plasma antiepileptic drug monitoring in a neurological practice: a 25-year experience. Ther. Drug Monit. 16(5), 458–468 (1994).
   PubMed Web of Science ®Google Scholar
• Schmidt D, Einicke I, Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch. Neurol. 43(3), 263–265 (1986).
   PubMed Web of Science ®Google Scholar
• Eadie MJ, Heazlewood R, Tyrer JH. How worthwhile is plasma primidone measurement? Clin. Exp. Neurol. 18, 123–131 (1981).
   PubMedGoogle Scholar
• McKauge L, Tyrer JH, Eadie MJ. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther. Drug Monit. 3(1), 63–70 (1981).
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Berry DJ, Bourgeois BF et al. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49(7), 1239–1276 (2008).
   PubMed Web of Science ®Google Scholar
• Levy RH, Yerby MS. Effects of pregnancy on antiepileptic drug utilization. Epilepsia 26(Suppl. 1), S52–S57 (1985).
   Google Scholar
• Lander CM, Eadie MJ. Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 32(2), 257–266 (1991).
   PubMed Web of Science ®Google Scholar
• Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 16(1), 99–110 (1975).
   PubMed Web of Science ®Google Scholar
• Schmidt D. The effect of pregnancy on the natural history of epilepsy: review of the literature. In: Epilepsy, Pregnancy and the Child. Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D (Eds). Raven Press, NY, USA, 3–14 (1982).
   Google Scholar
• Meadow SR. Congenital abnormalities and anticonvulsant drugs. Proc. R. Soc. Med. 63(1), 48–49 (1970).
   PubMedGoogle Scholar
• Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol. Scand. 112(3), 137–143 (2005).
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E et al. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiat. 77, 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Reimers A, Brodtkorb E. Second-generation antiepileptic drugs and pregnancy: a guide for clinicians. Expert Rev. Neurother. 12(6), 707–717 (2012).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N et al. Cognitive function at 3 years after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 360, 1587–1605 (2009).
   Google Scholar
• Meador KJ, Baker GA, Browning N et al.; NEAD Study Group. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology 78(16), 1207–1214 (2012).
   PubMed Web of Science ®Google Scholar
• Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 7(6), 525–537 (2008).
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 1(8), 477–482 (2002).
   PubMed Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7(6), 500–506 (2008).
   PubMed Web of Science ®Google Scholar
• Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol. 13(3), 277–282 (2006).
   PubMed Web of Science ®Google Scholar
• Shorvon S. The treatment of chronic epilepsy: a review of recent studies of clinical efficacy and side effects. Curr. Opin. Neurol. 20(2), 159–163 (2007).
   PubMed Web of Science ®Google Scholar
• Shinnar S, Pellock JM. Update on the epidemiology and prognosis of pediatric epilepsy. J. Child Neurol. 17(Suppl. 1), S4–S17 (2002).
   PubMed Web of Science ®Google Scholar
• Specchio LM, Tramacere L, La Neve A, Beghi E. Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy. J. Neurol. Neurosurg. Psychiatr. 72(1), 22–25 (2002).
   PubMed Web of Science ®Google Scholar
• Oller-Daurella L, Pamies R, Oller L. Reduction or discontinuance of antiepileptic drugs in patients seizure-free for more than 5 years. In: Epileptology. Janz D (Ed.). Thieme, Stuttgart, Germany 218–227 (1976).
   Google Scholar